Live Breaking News & Updates on Acumen Pharmaceuticals Trading Down

Stay updated with breaking news from Acumen pharmaceuticals trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Down 12.0% in May

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the target of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 816,000 shares, a decrease of 12.0% from the April 30th total of 926,900 shares. Based on an average trading volume of 297,900 shares, […] ....

Chicago , Illinois , United-states , Dekabank-deutsche-girozentrale , Acumen-pharmaceuticals-trading-down , Nasdaq , Institutional-investors-weigh-in-on-acumen-pharmaceuticals , Sg-americas-securities , Acumen-pharmaceuticals , Chicago-partners-investment-group , Acumen-pharmaceuticals-inc , News-ratings-for-acumen-pharmaceuticals-daily

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Insider Derek M. Meisner Sells 8,933 Shares

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Insider Derek M. Meisner Sells 8,933 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Chicago , Illinois , California , American , Derekm-meisner , Securities-exchange-commission , Acumen-pharmaceuticals-company-profile , Acumen-pharmaceuticals , Acumen-pharmaceuticals-trading-down , Deutsche-bank-aktiengesellschaft

Baystate Wealth Management LLC Purchases Shares of 18,020 Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Baystate Wealth Management LLC Purchases Shares of 18,020 Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News-ratings-for-acumen-pharmaceuticals-daily , Pinnacle-associates-ltd , Acumen-pharmaceuticals-inc , Acumen-pharmaceuticals-trading-down , Tower-research-capital , Acumen-pharmaceuticals-profile , Baystate-wealth-management , Nasdaq , Prelude-capital-management , Quarter-for-acumen-pharmaceuticals , Deutsche-bank-aktiengesellschaft

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Director Jeffrey L. Ives Sells 41,949 Shares

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) Director Jeffrey L. Ives sold 41,949 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $6.49, for a total value of $272,249.01. The sale was disclosed in a legal filing with the Securities & Exchange Commission, […] ....

United-states , America , News-ratings-for-acumen-pharmaceuticals-daily , Renaissance-technologies , Credit-suisse-group , Dimensional-fund-advisors , Cantor-fitzgerald , Boothbay-fund-management , Nasdaq , Institutional-investors-weigh-in-on-acumen-pharmaceuticals , Prelude-capital-management

FY2023 EPS Estimates for Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Boosted by Cantor Fitzgerald

FY2023 EPS Estimates for Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Boosted by Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Chicago , Illinois , Montreal , Quebec , Canada , America , Hedge-funds-weigh-in-on-acumen-pharmaceuticals , Acumen-pharmaceuticals , Securities-exchange-commission